Schizophrenia, sensory gating, and nicotinic receptors

Schizophrenia Bulletin

Volumn 24, Issue 2, 1998, Pages 189-202

  Adler, Lawrence E ^c   Olincy, Ann ^c   Waldo, Merilyne ^c   Harris, Josette G ^c   Griffith, Jay ^b   Stevens, Karen ^c   Flach, Karen ^c   Nagamoto, Herbert ^c   Bickford, Paula ^c   Leonard, Sherry ^c   Freedman, Robert ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b Aurora Mental Health Center   (United States)

^c Aurora Mental Health Center ^*

Author keywords

Acetylcholine; Habituation; Hippocampus; Interneurons

Indexed keywords

NICOTINIC RECEPTOR;

CHOLINERGIC SYSTEM; EVOKED AUDITORY RESPONSE; GENETIC SUSCEPTIBILITY; HUMAN; LEARNING; NEUROPSYCHIATRY; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SCHIZOPHRENIA; SMOKING;

EID: 0031751031     PISSN: 05867614     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.schbul.a033320     Document Type: Review

References (91)

1. Adler, L.E.; Gerhardt, G.A.; Franks, R.; Baker, N.; Nagamoto, H.; Drebing, C.; and Freedman, R. Sensory physiology and catecholamines in schizophrenia and mania. Psychiatry Research, 31:297-309, 1990.
2. Adler, L.E.; Hoffer, L.J., Griffith, J.; Waldo, M.C.; and Freedman, R. Normalization by nicotine of deficient auditory sensory gating in the relatives of schizophrenics. Biological Psychiatry, 32:607-616, 1992.
3. Adler, L.E.; Hoffer, L.D.; Wiser, A.; and Freedman, R. Normalization of auditory physiology by cigarette smoking in schizophrenic patients. American Journal of Psychiatry, 150:1856-1861, 1993.
4. Adler, L.E.; Pachtman, E.; Franks, R.; Pecevich, M.; Waldo, M.C.; and Freedman, R. Neurophysiological evidence for a defect in neuronal mechanisms involved in sensory gating in schizophrenia. Biological Psychiatry, 17:639-654, 1982.
5. Akbarian, S.; Kim, J.J.; Potkin, S.G.; Hagman, J.O.; Tafazzoli, A.; Bunney, W.E., Jr.; and Jones, E.G. Gene expression for glutamic acid decarboxylase is reduced without loss of neurons in prefrontal cortex of schizophrenics. Archives of General Psychiatry, 52:258-266, 1995.
6. Benes, P.M.; McSparren, J.; Bird, E.D.; SanGiovanni, J.P.; and Vincent, S.L. Deficits in small interneurons in prefrontal and cingulate cortices of schizophrenic and schizoaffective patients. Archives of General Psychiatry, 48:996-1001, 1991.
7. Benes, F.M.; Vincent, S.L.; Altsterberg, O.; Bird, E.D.; and SanGiovanni, J.P. Increased GABA-A receptor binding in superficial layers of cingulate cortex in schizophrenics. Journal of Neuroscience, 12:924-929, 1992.
8. Bickford, P.C.; Luntz-Leybman, V.; and Freedman, R. Auditory sensory gating in the rat hippocampus:Modulation by brainstem activity. Brain Research, 607:33-38, 1993.
9. Bickford-Wimer, P.C.; Nagamoto, H.; Johnson, R.; Adler, L.; Egan, M.; Rose, G.M.; and Freedman, R. Auditory sensory gating in hippocampal neurons:A model system in the rat. Biological Psychiatry, 27:183-192, 1990.
10. Bouttos, N.N.; Zouridakis, G.; and Overall, J. Replication and extension of P50 findings in schizophrenia. Clinical Electroencephalography, 22:40-45, 1991.
11. Broadbent, D.E. Decision and Stress. London, England:Academic Press, 1971.
12. Broide, R.S.; Robertson, R.T.; and Leslie, F.M. Regulation of alpha7 nicotinic receptors in the developing rat somatosensory cortex by thalamocortical afferents. Journal of Neuroscience, 16:2956-2971, 1996.
13. Brunello, N.; Masotto, C; Steardo, L.; Markstein, R.; and Racagni, G. New insights into the biology of schizophrenia through the mechanism of action of clozapine. Neuropsychopharmacology, 13:177-214, 1995.
14. Chan, J., and Quik, M. A role of the nicotinic alpha-bungarotoxin receptor in neurite outgrowth in PC-12 cells. Neuroscience, 56:441-451, 1993.
15. Chini, B,; Raimond, E.; Elgoyhen, A.B.; Moralli, D.; Balzaretti, M.; and Heinemann, S. Molecular cloning and chromosomal localization of the human 7-nicotinic receptor subunit gene (CHRNA7). Genomics, 19:379-381, 1994.
16. Churchland, P.S. Neurophilosophy: Toward a Unified Science of the Mind/Brain. Cambridge, MA:MIT Press, 1986.
17. Conrad, C.R. Decay theory of immediate memory. Nature, 179:831-837, 1957.
18. Coon, H.; Plaetke, R.; Holik, J.; Hoff, M.; Myles-Worsley, M.; Waldo, M.; Freedman, R.; and Byerley, W. Use of a neurophysiological trait in linkage analysis of schizophrenia. Biological Psychiatry, 34:277-289, 1993.
19. Couturier, S.; Bertrand, D.; Matter, J.M.; Hernandez, M.C.; Bertrand, S.; Millar, N.; Valera, S.; Barkas, T.; and Ballivet, M. A neuronal nicotinic acetylcholine receptor subunit (alpha7) is developmentally regulated and forms a homo-oligomeric channel blocked by alpha-BTX. Neuron, 5(6):847-856, 1990.
20. Cowan, N. Attention and Memory:An Integrated Framework. New York, NY:Oxford University Press, 1995.
21. Cummings, J.L.; Gorman, D.G.; and Shapira, J. Physostigmine ameliorates the delusions of Alzheimer's disease. Biological Psychiatry, 33:536-541, 1993.
22. Davis, H.; Mast, T.; Yoshie, N.; and Zerlin, S. The slow response of the human cortex to auditory stimuli:Recovery process. Electroencephalography and Clinical Neurophysiology, 21:105-113, 1966.
23. de Leon, J.; Dadvand, M.; Canuso, C.; White, A.O.; Stanilla, J.K.; and Simpson, G.M. Schizophrenia and smoking:An epidemiological survey in a state hospital. American Journal of Psychiatry, 152:453-455, 1995.
24. B receptors in the hippocampus have different pharmacological properties. Neuron, 1:585-591, 1988.
25. Eccles, J.C. The Inhibitory Pathways of the Central Nervous System. Springfield, IL:Charles C Thomas Publisher, 1969.
26. Erwin, RJ.; Mawhinney, H.M.; Gur, R.C.; and Gur, R.E. Midlatency evoked responses in schizophrenia. Biological Psychiatry, 22:40-45, 1991.
27. Flach, K.A.; Adler, L.E.; Gerhardt, G.A.; Miller, C.; Bickford, P.; and MacGregor, R.J. Sensory gating in a computer model of the CA3 neural network of the hippocampus. Biological Psychiatry. 40(12):1230-1245, 1996a.
28. Flach, K.A.; Gerhardt, G.A.; Freedman, R.; and Adler, L.E. Sensory gating in a computer model of the CA3 neural network of the hippocampus. Biological Psychiatry, 39:630, 1996b.
29. Freedman, R.; Adler, L.E.; Bickford, P.; Byerley, W.; Coon, H.; Cullum, C.M.; Griffith, J.M.; Harris, J.G.; Leonard, S.; Miller, C.; Myles-Worsley, M.; Nagamoto, H.T.; Rose, G.; and Waldo, M. Schizophrenia and nicotinic receptors. Harvard Review of Psychiatry, 2:179-192, 1994.
30. Freedman, R.; Adler, L.E.; Waldo, M.C.; Pachtman, E.; and Franks, R.D. Neurophysiological evidence for a defect in inhibitory pathways in schizophrenia:Comparison of medicated and drug-free patients. Biological Psychiatry, 18:537-551, 1983.
31. Freedman, R.; Coon, H.; Myles-Worsley, M.; Orr-Urteger A.; Olincy, A.; Davis, A.; Polymeropoulos, M.; Holik, J.; Hopkins, J.; Hoff, M.; Rosenthal, J.; Waldo, M.C. Reimherr, F.; Wender, P.; Yaw, J.; Young, D.A.; Breese, C.R.; Adams, C.; Patterson, D.; Adler, L.E.; Kruglyak, L.; Leonard, S.; and Byerley, W. Linkages of a neurophysiological deficit in schizophrenia to chromosome 15 locus. Proceedings of the National Academy of Sciences of the United States of America, 94:587-592, 1997.
32. Freedman, R.; Hall, M.; Adler, L.E.; and Leonard, S. Evidence in postmortem brain tissue for decreased numbers of hippocampal nicotinic receptors in schizophrenia. Biological Psychiatry, 38:22-33, 1995.
33. Freedman, R.; Wetmore, C.; Strömberg, I.; Leonard, S.; and Olson, L. α-Bungarotoxin binding to hippocampal interneurons:Immunocytochemical characterization and effects on growth factor expression. Journal of Neuroscience, 13:1965-1975, 1993.
34. Frey, P.W., and Ross, L.E. Rabbit eyelid conditioning:Effects of age, interstimulus interval, and intertrial interval. Developmental Psychobiology, 1:276-279, 1968.
35. 125I]alpha-Bungarotoxin binding marks primary sensory areas of developing rat neocortex. Brain Research, 501:223-234, 1989.
36. 3H]dopamine release from synaptosomes prepared from mouse striatum. Journal of Neurochemistry, 62:1390-1398, 1994.
37. Green, M. What are the functional consequences of neurocognitive deficits in schizophrenia? American Journal of Psychiatry, 153:321-330, 1996.
38. Greenman, M., and McClellan, T.A. Negative effects of a smoking ban on an inpatient psychiatry service. Hospital and Community Psychiatry, 42:408-412, 1991.
39. Griffith, J.M., and Freedman, R. Normalization of the auditory P50 gating deficit of schizophrenic patients after NREM, but not REM sleep. Psychiatry Research 56:271-278, 1995.
40. Griffith, J.M.; O'Neill, J.E.; Petty, F.; and Garver, D.L. Effection of nicotine and stage 2 sleep on auditory P50 gating in schizophrenia. [Abstract] Biological Psychiatry, 39:652, 1996.
41. Griffith, J.M.; Waldo, M.; Adler, L.E.; and Freedman, R. Normalization of auditory sensory gating in schizophrenics after a brief period for sleep. Psychiatric Research, 49(1):29-39, 1993.
42. Grunze, H.C.R.; Rainnie, D.G.; Hasselmo, M.E.; Barkai, E.; Heam, E.F.; McCarley, R.W.; and Greene, R.W. NMDA-dependent modulation of CA1 local circuit inhibition. Journal of Neuroscience, 16:2034-2043, 1996.
43. Guterman, Y.; Josiassen, R.C.; and Bashore, T.R., Jr. Attentional influence on the P50 component of the auditory event-related brain potential. International Journal of Psychophysiology, 12:197-209, 1992.
44. Hamera, E.; Schneider, J.K.; and Deviney, S. Alcohol, cannabis, nicotine, and caffeine use and symptom distress in schizophrenia. Journal of Nervous and Mental Disease, 183(3):559-565, 1995.
45. Hammond, N.V., and Gruzelier, J.H. Laterality, attention and rate effects in the auditory temporal discrimination of schizophrenics:The effect of treatment with chlorpromazine. Quarterly Journal of Experimental Psychology, 30:91-103, 1978.
46. 3H]nicotine. Acta Physiologica Scandinavica, 132:1-14, 1988.
47. Harris, J.G.; Adler, L.E.; Young, D.A.; Cullum, CM.; Rilling, L.M.; Cicerello, A.; Intemann, P.M.; and Freedman, R. Neuropsychological dysfunction in parents of schizophrenics. Schizophrenia Research, 20(3):253-260, 1996.
48. Harrison, J.B.; Buchwald, J.S.; Kaga, K.; Woolf, N.J.; and Butcher, L. 'Cat P300' disappears after septal lesions. Electroencephalography and Clinical Neurophysiology, 69:55-64, 1988.
49. Hasselmo, M.E.; Schnett, E.; and Barkai, E. Dynamics of learning and recall at excitatory recurrent synapses and cholinergic modulation in rat hippocampal region CA3. Journal of Neuroscience, 15:5249-5262, 1995.
50. Hebb, D.O. Organization of Behavior. New York, NY:John Wiley & Sons, 1949.
51. B antagonists diminish the inhibitory gating of auditory response in the rat hippocampus. Neuroscience Letters, 190:133-136, 1995.
52. Hughes, J.R.; Hatsukami, D.K.; Mitchell, J.E.; and Dahlgren, I.A. Prevalence of smoking among psychiatric outpatients. American Journal of Psychiatry, 143:993-997, 1986.
53. Hunt, P., and Schmidt, J. The electron microscope autoradiographic localization of alpha-bungarotoxin binding sites within the central nervous system of the rat. Brain Research, 142:142-159, 1978.
54. Isaacson, J.S.; Solis, J.M.; and Nicoll, R.A. Local and diffuse synaptic actions of GABA in the hippocampus. Neuron, 10:165-175, 1993.
55. Jenkusky, S.M. Use of nicotine patches for schizophrenic patients. [Letter] American Journal of Psychiatry, 150(12):1899, 1993.
56. Johnson, S.W.; Palmer, M.R.; and Freedman, R. Effects of dopamine on spontaneous and evoked activity of caudate neurons. Neuropharmacology, 22:843-851, 1983.
57. Judd, L.L.; McAdams, L.; Budnick, B.; and Braff, D.L. Sensory gating deficits in schizophrenia:New results. American Journal of Psychiatry, 149:488-493, 1992.
58. Karson, C.N.; Casanova, M.F.; Kleinman, J.E.; and Griffin, W.S. Choline acetyltransferase in schizophrenia. American Journal of Psychiatry, 150:454-459, 1993.
59. Kathmann, N., and Engel, R.R. Sensory gating in normals and schizophrenics:A failure to find strong P50 suppression in normals. Biological Psychiatry, 27:1216-1226, 1990.
60. Kirch, D.G.; Bigelow, L.B.; Weinberger, D.R.; Lawson, W.B.; and Wyatt, R.J. Polydipsia and chronic hyponatremia in schizophrenic inpatients. Journal of Clinical Psychiatry, 46:179-181, 1985.
61. Kirch, D.G.; Gerhardt, G.A.; Shelton, R.C.; Freedman, R.; and Wyatt, R.J. Effect of chronic nicotine administration on monoamine and monoamine metabolite concentration in rat brain. Clinical Neuropharmacology, 10(4):376-383, 1987.
62. Koester, J. Voltage-geared channels and the generation of the action potential. In:Kandel, E.R.; Schwartz, J.H.; and Jessell, T.M., eds. Principles of Neural Science. Vol. 1. New York, NY:Elsevier Science Publishers, 1991. pp. 104-118.
63. Kohonen, T. Self-Organization and Associative Memory. Berlin, Germany:Springer-Verlag, 1984.
64. Lang, W., and Henke, H. Cholinergic receptor binding and autoradiography in brains of non-neurological and senile dementia of Alzheimer-type patients. Brain Research, 267(2):271-280, 1983.
65. Leonard, S.; Adams, C.; Bresse, C.R.; Adler, L.E.; Bickford, P.; Byerley, W.; Coon, H.; Griffith, J.M.; Miller, C.; Myles-Worsley, M.; Nagamoto, H.T.; Rollins, Y.; Stevens, K.E.; Waldo, M.; and Freedman, R. Nicotinic receptor function in schizophrenia. Schizophrenia Bulletin, 22(3):431-445, 1996.
66. Luntz-Leybman, V.; Bickford, P.C.; and Freedman, R. Cholinergic gating of response to auditory stimuli in rat hippocampus. Brain Research, 587:130-136, 1992.
67. Marks, M.J., and Collins, A.C. Characterization of nicotine binding in mouse brain and comparison with binding of alpha-bungarotoxin and quinuclidinyl benzilate. Molecular Pharmacology, 22:554-564, 1982.
68. McEvoy, J.P.; Rose, I.E.; Levin, E.D.; VanderZwaag, C.; and McGee, M. Clozapine decreases drive to smoke. [Abstract] Schizophrenia Research, 11:104, 1994.
69. McGehee, D.S.; Heath, M.J.; Gelber, S.; Devay, P.; and Role, L.W. Nicotine enhancement of fast excitatory transmission in CNS by presynaptic receptors. Science, 269:1692-1696, 1995.
70. Miller, C., and Freedman, R. The activity of hippocampal interneurons and pyramidal cells during the response of the hippocampus to repeated auditory stimuli. Neuroscience, 69:371-381, 1995.
71. Miller, R.R. Effects of smoking on drug action. Pharmacology and Therapeutics, 2:749-756, 1977.
72. Nagamoto, H.T.; Adler, L.E.; Hea, R.A.; Griffith, J.M.; McRae, K.A.; and Freedman, R. Gating of auditory P50 in schizophrenics:Unique effects of clozapine. Biological Psychiatry, 40(3):181-188, 1996.
73. Nagamoto, H.T.; Adler, L.E.; Waldo, M.C.; Griffith, J.; and Freedman, R. Gating of auditory response in schizophrenics and normal controls:Effects of recording site and stimulation interval in the P50 wave. Schizophrenia Research, 4(1):31-40, 1991.
74. Oleskevich, S., and Lacaille, J.C. Reduction of GABA-B inhibitory postsynaptic potentials by serotonin via preand postsynaptic mechanisms in CA3 pyramidal cells of rat hippocampus in vitro. Synapse, 12:173-188, 1992.
75. Olincy, A.; Ross, R.G.; Young, D.A.; Roath, M.; and Freedman, R. Smooth pursuit eye movements after smok- ing in schizophrenic patients. [Abstract] Biological Psychiatry, 39:574, 1996.
76. Olincy, A.; Young, D.A.; and Freedman, R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biological Psychiatry, 42(1):1-5, 1997.
77. Overall, J.E., and Gorham, D.R. The Brief Psychiatric Rating Scale. Psychological Reports, 10:799-812, 1962.
78. Pugh, P.C., and Berg, D.K. Neuronal acetylcholine receptors that bind alpha-bungarotoxin mediate neurite retraction in a calcium-dependent manner. Journal of Neuroscience, 14:889-896, 1994.
79. Rolls, E.T. Theoretical and neurophysiological analysis of the functions of the primate hippocampus in memory. Cold Spring Harbor Symposia on Quantitative Biology, 55:995-1006, 1990.
80. Schoepfer, R.; Conroy, W.G.; Whiting, P.; Gore, M.; and Lindstrom, J. Brain-bungarotoxin binding protein cDNAs and MAbs reveal subtypes of this branch of the ligandgated ion channel gene superfamily. Neuron, 5:35-48, 1990.
81. Séguéla, P.; Wadiche, J.; Dineley-Miller, K.; Dani, J.A.; and Patrick, J.W. Molecular cloning, functional properties, and distribution of rat brain α7:A nicotinic cation channel highly permeable to calcium. Journal of Neuroscience, 13:596-604, 1993.
82. Siegel, C.; Waldo, M.; Mizner, G.; Adler, L.E.; and Freedman, R. Deficits in sensory gating in schizophrenic patients and their relatives. Archives of General Psychiatry, 41:607-612, 1984.
83. Stevens, K.E.; Freedman, R.; Collins, A.C.; Hall, M.; Leonard, S.; Marks, M.J.; and Rose, G.M. Genetic correlation of inhibitory gating of hippocampal auditory evoked response and alpha-bungarotoxin-binding nicotinic cholinergic receptors in inbred mouse strains. Neuropsychopharmacology, 15(2):152-162, 1996.
84. Suddath, R.L.; Christison, G.W.; Torrey, E.F.; Casanova, M.F.; and Weinberger, D.R. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. New England Journal of Medicine, 322(12):789-794, 1990.
85. Szymusiak, R.; Moriarity, S.; and McGinty, D. Excitation of basal forebrain neurons by pedunculopontine stimulation. [Abstract] Abstracts:Society for Neuroscience, 345, 1991.
86. Venables, P. Input dysfunction in schizophrenia. In:Maher, B.A., ed. Progress in Experimental Personality Research. New York, NY:Academic Press, 1964. pp. 1-47.
87. 2+. Neuron, 8:353-362, 1992.
88. Vinogradov, S.; Solomon, S.; Ober, B.A.; Biggins, C.A.; Shenaut, G.K.; and Fein, G. Do semantic priming effects correlate with sensory gating in schizophrenia? Biological Psychiatry, 39:821-824, 1996.
89. Vinogradova, O. Functional organization of the limbic system in the process of registration of information. In:Issacson, R.L., and Pribram, K.H., eds. The Hippocampus:Neurophysiology and Behavior. Vol. 1. New York, NY:Plenum Press, 1975, pp. 3-69.
90. Waldo, M.C.; Cawthra, E.; Adler, L.E.; Dubester, S.; Staunton, M.; Nagamoto, H.; Baker, N.; Madison, A.; Simon, J.; Scherzinger, A.; Drebing, C.; Gerhardt, G.; and Freedman, R. Auditory sensory gating, hippocampal volume, and catecholamine metabolism in schizophrenics and their siblings. Schizophrenia Research, 12:93-106, 1994.
91. Zola-Morgan, S.; Squire, S.L.; and Amaral, D.G. Human amnesia and the medial temporal region:Enduring memory impairment following a bilateral lesion limited to field CA1 of the hippocampus. Journal of Neuroscience, 6:2950-2967, 1986.